Literature DB >> 24950725

Predicting the pathological features of the mesorectum before the laparoscopic approach to rectal cancer.

Sonia Fernández Ananín1, Eduardo M Targarona, Carmen Martinez, Juan Carlos Pernas, Diana Hernández, Ignasi Gich, Francesc J Sancho, Manuel Trias.   

Abstract

Pelvic anatomy and tumour features play a role in the difficulty of the laparoscopic approach to total mesorectal excision in rectal cancer. The aim of the study was to analyse whether these characteristics also influence the quality of the surgical specimen. We performed a prospective study in consecutive patients with rectal cancer located less than 12 cm from the anal verge who underwent laparoscopic surgery between January 2010 and July 2013. Exclusion criteria were T1 and T4 tumours, abdominoperineal resections, obstructive and perforated tumours, or any major contraindication for laparoscopic surgery. Dependent variables were the circumferential resection margin (CMR) and the quality of the mesorectum. Sixty-four patients underwent laparoscopic sphincter-preserving total mesorectal excision. Resection was complete in 79.1% of specimens and CMR was positive in 9.7%. Univariate analysis showed tumour depth (T status) (P = 0.04) and promontorium-subsacrum angle (P = 0.02) independently predicted CRM (circumferential resection margin) positivity. Tumour depth (P < 0.05) and promontorium-subsacrum axis (P < 0.05) independently predicted mesorectum quality. Multivariate analysis identified the promontorium-subsacrum angle (P = 0.012) as the only independent predictor of CRM. Bony pelvis dimensions influenced the quality of the specimen obtained by laparoscopy. These measurements may be useful to predict which patients will benefit most from laparoscopic surgery and also to select patients in accordance with the learning curve of trainee surgeons.

Entities:  

Mesh:

Year:  2014        PMID: 24950725     DOI: 10.1007/s00464-014-3622-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  31 in total

1.  Pelvic anatomy as a factor in laparoscopic rectal surgery: a prospective study.

Authors:  Jeong Yeon Kim; Yong Wan Kim; Nam Kyu Kim; Hyuk Hur; KangYong Lee; Byung Soh Min; Hyun Jae Cho
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2011-10       Impact factor: 1.719

2.  Factors influencing the quality of total mesorectal excision.

Authors:  B Garlipp; H Ptok; U Schmidt; P Stübs; H Scheidbach; F Meyer; I Gastinger; H Lippert
Journal:  Br J Surg       Date:  2012-02-06       Impact factor: 6.939

3.  Laparoscopic versus open surgery for rectal cancer: long-term oncologic results.

Authors:  Christophe Laurent; Fabien Leblanc; Philippe Wütrich; Mathieu Scheffler; Eric Rullier
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

Review 4.  Robotic surgery: colon and rectum.

Authors:  Seong Kyu Baek; Joseph C Carmichael; Alessio Pigazzi
Journal:  Cancer J       Date:  2013 Mar-Apr       Impact factor: 3.360

5.  The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma.

Authors:  F Bretagnol; B Lelong; C Laurent; V Moutardier; A Rullier; G Monges; J-R Delpero; E Rullier
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

Review 6.  Modern management of colorectal cancer--a pathologist's view.

Authors:  N J Maughan; P Quirke
Journal:  Scand J Surg       Date:  2003       Impact factor: 2.360

7.  Factors predicting the quality of total mesorectal excision for rectal cancer.

Authors:  Daniel Leonard; Freddy Penninckx; Steffen Fieuws; Anne Jouret-Mourin; Christine Sempoux; Constant Jehaes; Elizabeth Van Eycken
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

8.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

9.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

10.  Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases.

Authors:  Seung Hyuk Baik; Nam Kyu Kim; Kang Young Lee; Seung Kook Sohn; Chang Hwan Cho; Myeong Jin Kim; Hogeun Kim; Rina K Shinn
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

View more
  5 in total

1.  Pelvic inlet shape measured by three-dimensional pelvimetry is a predictor of the operative time in the anterior resection of rectal cancer.

Authors:  Takehiro Shimada; Masashi Tsuruta; Hirotoshi Hasegawa; Koji Okabayashi; Takashi Ishida; Yusuke Asada; Hirofumi Suzumura; Yuko Kitagawa
Journal:  Surg Today       Date:  2017-06-08       Impact factor: 2.549

2.  Mental practice with interactive 3D visual aids enhances surgical performance.

Authors:  Marina Yiasemidou; Daniel Glassman; Faisal Mushtaq; Christos Athanasiou; Mark-Mon Williams; David Jayne; Danilo Miskovic
Journal:  Surg Endosc       Date:  2017-03-10       Impact factor: 4.584

3.  Predictors of surgical outcomes and survival in rectal cancer patients undergoing laparoscopic total mesorectal excision after neoadjuvant chemoradiation therapy: the interest of pelvimetry and restaging magnetic resonance imaging studies.

Authors:  Nicola de'Angelis; Frederic Pigneur; Aleix Martínez-Pérez; Giulio Cesare Vitali; Filippo Landi; Teresa Torres-Sánchez; Victor Rodrigues; Riccardo Memeo; Giorgio Bianchi; Francesco Brunetti; Eloy Espin; Frederic Ris; Alain Luciani
Journal:  Oncotarget       Date:  2018-05-18

Review 4.  Present status and perspectives of endosonography 2017 in gastroenterology.

Authors:  Michael Hocke; Barbara Braden; Christian Jenssen; Christoph F Dietrich
Journal:  Korean J Intern Med       Date:  2017-11-23       Impact factor: 2.884

5.  Anatomical basis for the choice of laparoscopic surgery for low rectal cancer through the pelvic imaging data-a cohort study.

Authors:  Zhou Yang; Guo Chunhua; Yuan Huayan; Yang Jianguo; Cheng Yong
Journal:  World J Surg Oncol       Date:  2018-10-05       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.